A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Arvinas, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 144,400 shares of ARVN stock, worth $2.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
144,400
Previous 275,400 47.57%
Holding current value
$2.76 Million
Previous $7.33 Million 51.49%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.66 - $32.73 $3.1 Million - $4.29 Million
-131,000 Reduced 47.57%
144,400 $3.56 Million
Q2 2024

Aug 09, 2024

SELL
$24.46 - $40.4 $2.12 Million - $3.5 Million
-86,573 Reduced 23.92%
275,400 $7.33 Million
Q1 2024

May 13, 2024

BUY
$36.38 - $52.31 $4.53 Million - $6.51 Million
124,400 Added 52.36%
361,973 $14.9 Million
Q4 2023

Feb 13, 2024

BUY
$14.19 - $42.33 $1.76 Million - $5.24 Million
123,873 Added 108.95%
237,573 $9.78 Million
Q3 2023

Nov 14, 2023

SELL
$19.64 - $28.21 $547,956 - $787,059
-27,900 Reduced 19.7%
113,700 $2.23 Million
Q2 2023

Aug 11, 2023

BUY
$21.73 - $31.43 $2.01 Million - $2.91 Million
92,700 Added 189.57%
141,600 $3.52 Million
Q1 2023

May 12, 2023

BUY
$26.15 - $37.26 $1.28 Million - $1.82 Million
48,900 New
48,900 $1.34 Million
Q2 2022

Aug 12, 2022

SELL
$36.01 - $74.24 $4.05 Million - $8.34 Million
-112,400 Reduced 86.2%
18,000 $758,000
Q1 2022

May 13, 2022

SELL
$60.27 - $81.57 $385,728 - $522,047
-6,400 Reduced 4.68%
130,400 $8.78 Million
Q4 2021

Feb 11, 2022

BUY
$65.85 - $96.21 $3.54 Million - $5.18 Million
53,800 Added 64.82%
136,800 $11.2 Million
Q3 2021

Nov 12, 2021

SELL
$73.2 - $107.87 $7.33 Million - $10.8 Million
-100,200 Reduced 54.69%
83,000 $6.82 Million
Q2 2021

Aug 13, 2021

SELL
$60.45 - $84.26 $2.98 Million - $4.15 Million
-49,300 Reduced 21.2%
183,200 $14.1 Million
Q1 2021

May 13, 2021

BUY
$58.19 - $91.37 $8.14 Million - $12.8 Million
139,900 Added 151.08%
232,500 $15.4 Million
Q4 2020

Feb 10, 2021

BUY
$20.19 - $84.93 $1.87 Million - $7.86 Million
92,600 New
92,600 $7.87 Million
Q3 2020

Nov 13, 2020

SELL
$22.99 - $36.34 $2.13 Million - $3.36 Million
-92,500 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$29.88 - $56.74 $3.82 Million - $7.26 Million
-127,995 Reduced 58.05%
92,500 $3.1 Million
Q1 2020

May 14, 2020

BUY
$33.0 - $54.5 $2.35 Million - $3.89 Million
71,295 Added 47.78%
220,495 $8.89 Million
Q4 2019

Feb 13, 2020

BUY
$15.39 - $44.38 $2.3 Million - $6.62 Million
149,200 New
149,200 $6.13 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.